Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

FDG-PET Findings of Intraductal Oncocytic Papillary Neoplasms of the Pancreas: Two Case Reports.

Kato T, Ikari S, Hirata K, Machida T, Nakamura H, Meguro T, Morita T, Takahashi T, Tamaki N, Horita S.

Case Rep Gastroenterol. 2012 May;6(2):415-24. doi: 10.1159/000339916. Epub 2012 Jun 26.

2.

Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.

Reid MD, Stallworth CR, Lewis MM, Akkas G, Memis B, Basturk O, Adsay V.

Cancer Cytopathol. 2016 Feb;124(2):122-34. doi: 10.1002/cncy.21627. Epub 2015 Sep 28.

3.

Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.

Basturk O, Chung SM, Hruban RH, Adsay NV, Askan G, Iacobuzio-Donahue C, Balci S, Zee SY, Memis B, Shia J, Klimstra DS.

Virchows Arch. 2016 Nov;469(5):523-532. Epub 2016 Sep 3.

PMID:
27591765
4.

Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.

Takanami K, Hiraide T, Tsuda M, Nakamura Y, Kaneta T, Takase K, Fukuda H, Takahashi S.

Ann Nucl Med. 2011 Aug;25(7):501-10. doi: 10.1007/s12149-011-0494-y. Epub 2011 May 3.

PMID:
21537945
5.

18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.

Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.

Ann Surg. 2007 Dec;246(6):932-7; discussion 937-9.

PMID:
18043094
6.

Intraductal oncocytic papillary neoplasm of the pancreas with strong accumulation on FDG-PET.

Kato Y, Nakagouri T, Konishi M, Takahashi S, Gotoda N, Hasebe T, Kinosita T.

Hepatogastroenterology. 2008 May-Jun;55(84):900-2.

PMID:
18705293
7.

Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas.

Tomimaru Y, Takeda Y, Tatsumi M, Kim T, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, Kitagawa T, Nagano H, Umeshita K, Wakasa K, Doki Y, Mori M.

Oncol Rep. 2010 Sep;24(3):613-20.

PMID:
20664965
8.

Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis.

Basturk O, Khayyata S, Klimstra DS, Hruban RH, Zamboni G, Coban I, Adsay NV.

Am J Surg Pathol. 2010 Mar;34(3):364-70. doi: 10.1097/PAS.0b013e3181cf8bb6.

9.

[Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas Showing High Accumulation of 18F-Fluorodeoxyglucose (FDG)--A Case Report].

Kubota M, Nishimura M, Nakatsuka R, Miyazaki S, Danno K, Motoori M, Matsuda C, Fujitani K, Iwase K.

Gan To Kagaku Ryoho. 2015 Nov;42(12):2394-6. Japanese.

PMID:
26805375
10.
11.

Use of F-18 fluorodeoxyglucose positron emission tomography with dual-phase imaging to identify intraductal papillary mucinous neoplasm.

Saito M, Ishihara T, Tada M, Tsuyuguchi T, Mikata R, Sakai Y, Tawada K, Sugiyama H, Kurosawa J, Otsuka M, Uchida Y, Uchiyama K, Miyazaki M, Yokosuka O.

Clin Gastroenterol Hepatol. 2013 Feb;11(2):181-6. doi: 10.1016/j.cgh.2012.10.037. Epub 2012 Nov 6.

PMID:
23142206
12.

Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.

Pedrazzoli S, Sperti C, Pasquali C, Bissoli S, Chierichetti F.

Ann Surg. 2011 Dec;254(6):971-6. doi: 10.1097/SLA.0b013e3182383137.

PMID:
22076067
13.

A large mural nodule in branch duct intraductal papillary mucinous adenoma of the pancreas: a case report.

Haruki K, Wakiyama S, Futagawa Y, Shiba H, Misawa T, Yanaga K.

Surg Case Rep. 2015 Dec;1(1):20. doi: 10.1186/s40792-014-0009-x. Epub 2015 Feb 24.

14.

The utility of F-18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm.

Hong HS, Yun M, Cho A, Choi JY, Kim MJ, Kim KW, Choi YJ, Lee JD.

Clin Nucl Med. 2010 Oct;35(10):776-9. doi: 10.1097/RLU.0b013e3181e4da32.

PMID:
20838285
15.

Intraductal oncocytic papillary neoplasm of the pancreas: a case of a second neoplasm in a pancreas cancer survivor.

Garg MS, Schuerle T, Liu Y, Thakkar SJ.

JOP. 2015 Jan 31;16(1):63-5. doi: 10.6092/1590-8577/2899.

16.

Intraductal oncocytic papillary neoplasm of the pancreas: a radio-pathological case study.

Fischer MA, Donati O, Heinrich S, Weber A, Hany TF, Soldini D, Alkadhi H, Marincek B, Scheffel H.

JOP. 2010 Jan 8;11(1):49-54.

17.

Intraductal oncocytic papillary neoplasms of the pancreas and bile ducts: a description of five new cases and review based on a systematic survey of the literature.

Liszka L, Pajak J, Zielińska-Pajak E, Krzych L, Gołka D, Mrowiec S, Lampe P.

J Hepatobiliary Pancreat Sci. 2010 May;17(3):246-61. doi: 10.1007/s00534-010-0268-2. Epub 2010 Mar 4. Review.

PMID:
20464560
18.

Intrahepatic Biliary Intraductal Oncocytic Papillary Neoplasm/Carcinoma: First Reported Case in Australia and Literature Review.

Chu C, Felbel W, Chu F.

Radiol Case Rep. 2015 Dec 7;2(3):95. doi: 10.2484/rcr.v2i3.95. eCollection 2007.

19.

Intraductal oncocytic papillary neoplasm of the extrahepatic biliary tree: first report.

Spector SA, Bejarano PA, Amortegui JD, Renfrow MR, Livingstone AS.

Am Surg. 2004 Jan;70(1):55-8.

PMID:
14964549
20.

SLC2A1/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas.

Oda Y, Aishima S, Shindo K, Fujino M, Mizuuchi Y, Hattori M, Miyazaki T, Tanaka M, Oda Y.

Hum Pathol. 2017 Apr 12. pii: S0046-8177(17)30090-4. doi: 10.1016/j.humpath.2017.03.008. [Epub ahead of print]

PMID:
28412205

Supplemental Content

Support Center